So why has POH has been so silent lately and not showing any signs of useful product work/announcements.
They've been BUSY interviewing potential new Directors.
So NOW we're paying all these Directors to manage a business that really doesn't have a lot new to offer anyone (versus 1,2,3 years ago) except talk of "potential this & potential that". They need to get on with completing any/all clinical trials and give the market proven reasons to be interested in doing business with POH.
Three new Directors appointed, page-15
-
- There are more pages in this discussion • 81 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
-0.001(33.3%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.2¢ | $2.23K | 751.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 63 | 102805577 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 23045578 | 12 |
View Market Depth
| Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |